GYL Financial Synergies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $6.92M | Sell |
14,882
-276
| -2% | -$128K | 0.52% | 49 |
|
2024
Q2 | $7.1M | Buy |
15,158
+30
| +0.2% | +$14.1K | 0.55% | 45 |
|
2024
Q1 | $6.32M | Sell |
15,128
-95
| -0.6% | -$39.7K | 0.5% | 52 |
|
2023
Q4 | $6.19M | Buy |
15,223
+272
| +2% | +$111K | 0.51% | 49 |
|
2023
Q3 | $5.2M | Buy |
14,951
+406
| +3% | +$141K | 0.51% | 49 |
|
2023
Q2 | $5.12M | Buy |
+14,545
| New | +$5.12M | 0.47% | 53 |
|